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Microparticles (MPs) play essential roles in cell-cell crosstalk throw car-
rying bioactive molecules such as proteins and microRNAs (miRNAs). For
this study, the MPs profile was explored in order to understand their implica-
tion in endothelial dysfunction in a group of obese (n=69, BMI≥30Kg/m²) and
normal weight subjects (n=46, BMI<25Kg/m²) recruited at F. Hached Hospital
(Sousse, Tunisia). Vascular endothelial function was assessed by the explora-
tion of the endothelium-dependent vasodilation by Laser Doppler Flowmetry.
Circulating MPs were quantified by flow cytometry analysis. Firstly, endothe-
lial dysfunction was detected by an impaired cutaneous vascular conductance
(CVC) in obese patients in comparison to normal subjects, 0,34±0,03 versus
0,47±0,05 PU/mmHg respectively (p=0,029). Inflammation was significantly
increased (CRPus x 3,5) as well as oxidant stress (AOPP, TBARS) in obese
patients. On the other hand, enhanced circulating MPs levels were detected in
obese patients 14792,6±1755,6 MPs/μl plasma in comparison to normal sub-
jects 8480,7±1431,9 MPs/μl plasma (p=0,031). Therefore, we explored
inflammation associated-miRNAs in MPs of sub-groups of obese (n=10) and
normal subjects (n=10). The analysis of individual miRNAs (miR-150, miR-
146a, miR-320a, miR-124a, miR-223, miR-155, and miR-302a) was assessed
by real time PCR. Among them, miR-150, miR-146a, miR-320a and miR-
124a were significantly enhanced in the obese group, miR-223 were identical
in each group while miR-155a and miR-302a couldn’t be detected in MPs.
Multivariate analyses revealed a positive correlation between miR-124a and
CVC (r=0,807; p=0,009), and a positive correlation between miR320a and cir-
culating MPs level (r=0,519; p=0,033). Our results are highlighting the impor-
tance of considering the MPs-containing miRNAs as effectors in the process
of the endothelial dysfunction in obesity, however, more studies are necessary
to understand the precise role these miRNAs.
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Pyridostigmine (PIR), a reversible anticholinestesic, has its cardioprotec-
tive effects demonstrated by the reduction of the QT interval of the eletro-
cardiogram ECG in patients with heart deases. Experimentally this QT
prolongation is induced by adrenergic stimulation. However, its short half-life
and the incidence of side effects are factors that limit its prolonged use. This
study was aimed to investigate the cardioprotective activity of pyridostigmine
conveyed in convetional multilamelar liposomes administered subcutaneously.
Two multilamellar liposomal formulations were developed and tested: one
consisting of dioleil phosphatidylcholine (DOPC) and cholesterol (CHOL) and
the other consisting of diasteroylphosphatidylcholine (DSPC) and CHOL. The
encapsulation efficiency determined was 15,4% and 23,4% respectively. The
cardioprotective activity of PIR was evaluated in rats for its ability to prevent
cardiovascular disorders, demonstrated, in signs of blood pressure (BP) and
ECG induced by IV administration of noradrenaline (NA). After administra-
tion of 10mg/kg NA, the DSPC and DOPC liposomal formulations containing
PIR were able to reduce significantly the QT interval, with a maximum inhi-
bition of 76.4% and 73.0% respectively. Both formulations DSPC: CHOL and
DOPC: CHOL, attenuated the increase in BP within 12 to 24 hours respec-
tively. As the QT prolongation is a predictior of sudden death and the PIR was
able to prevent its prolongation after sympathetic stimulation, it could be sug-
gested that PIR in liposomes administered sbcutaneously has cardioprotective
activity.
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Cardiac cellular therapy can be intended by stimulation of “endogenous”
cardiac precusor cells (CPCs), identified by several markers such as the Stem
Cell Antigen 1 (Sca-1) or the stem cell factor c-kit. CPCs are able to prolif-
erate and differentiate into beating cardiomyocytes in vivo and in vitro after
brain natriuretic peptide (BNP) treatment.
BNP is a cardiac hormone, whose role in the heart remains to be clari-
fied. Interestingly, BNP treatments, in vivo and in vitro, induced an up-
regulation of mRNA coding for Sca-1 and a 2 fold increase of the number
of CPCs. In previous work, we showed that Sca-1 KO mice had two times
less CPCs, and two times less BNP mRNA expression compared to Wild
Type mice.
The aim of this project is to determine whether the effect of BNP on CPCs
is linked to Sca-1 expression.
Sca-1 KO mice developed a dilated cardiomyopathy with ageing. To deter-
mine whether reduced amount of BNP is responsible for the development of
this cardiac disease, neonatal Sca-1 KO mice were treated with BNP for
2 weeks. Mice were sacrificed 13 weeks later, and cardiac parameters were
measured by echocardiography. The thickness of the left ventricular posterior
wall and the ejection fraction were increased in BNP-treated Sca-1 deficient
mice (+15% and + 28%, respectively) compared to untreated Sca-1 KO mice.
To explore the cellular mechanisms, in vitro experiments were per-
formed. Non Myocytes cells (NMCs), containing CPCs, have been isolated
from the heart of Sca-1 KO mice and cultured with or without BNP in media
favouring either cell proliferation or differentiation into cardiomyocytes.
BNP is not able to induce Sca-1KO cell proliferation, whereas CPC differ-
entiation into cardiomyocytes is maintained even in absence of Sca-1
expression.
In conclusion, BNP modulates the cardiomyopathy developed by Sca-1 KO
mice. BNP effect on CPC proliferation is linked to Sca-1 expression, but its
effect on differentiation is Sca-1 independent.
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Microparticles (MPs) are small vesicles released from the plasma mem-
brane of activated and/or apoptotic cells. We have previously shown that
MPs generated from apoptotic T cells induce endothelial dysfunction
through a decrease of nitric oxide production (NO). In this study we
hypothesize that the mechanism by which MPs induce endothelial dysfunc-
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